Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M. (Rineke) B. L. Leys"'
Autor:
Bronno van der Holt, Anders Waage, Niels W.C.J. van de Donk, E. (Vera) J. M. Mattijssen, M. (Rineke) B. L. Leys, Annette W. G. van der Velden, Mark-David Levin, Harm Sinnige, Klaas G. van der Hem, Morten Salomo, Bea Tanis, Einar Haukås, Ulf-Henrik Mellqvist, Matthijs Westerman, Rolf Brouwer, Pieter Sonneveld, Saskia K. Klein, Astrid Gruber, Gerard M. J. Bos, Marian Stevens-Kroef, Markus Hansson, Damian L. Szatkowski, Wendy Deenik, Torben Plesner, Sonja Zweegman, Marc Durian, Heleen Visser-Wisselaar, Juleon Coenen
Publikováno v:
Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M R B L, Sinnige, H A M, Haukås, E, van der Hem, K G, Durian, M F, Mattijssen, E V J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
Blood, 127(9), 1109-1116. American Society of Hematology
Blood, 127(9), 1109-1116. The American Society of Hematology
Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M B L, Sinnige, H A M, Haukas, E, van der Hem, K G, Durian, M F, Mattijssen, E J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
Blood, 127, 1109-16
Blood, 127, 9, pp. 1109-16
Blood, 127(9), 1109-1116. American Society of Hematology
Blood, 127(9), 1109-1116. The American Society of Hematology
Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M B L, Sinnige, H A M, Haukas, E, van der Hem, K G, Durian, M F, Mattijssen, E J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
Blood, 127, 1109-16
Blood, 127, 9, pp. 1109-16
The combination of melphalan, prednisone, and thalidomide (MPT) is considered standard therapy for newly diagnosed patients with multiple myeloma who are ineligible for stem cell transplantation. Long-term treatment with thalidomide is hampered by ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27be0ae01cb43dea87bdd45a3473c8b5
https://portal.findresearcher.sdu.dk/da/publications/767d554b-0302-426c-b3cf-03650e95cbc9
https://portal.findresearcher.sdu.dk/da/publications/767d554b-0302-426c-b3cf-03650e95cbc9
